NCT06718920 Adverse Childhood Experiences in Patients With MS: Impact on Quality of Life and on Coping Strategies Towards the Disease and Its Treatment
| NCT ID | NCT06718920 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Fondazione Policlinico Universitario Agostino Gemelli IRCCS |
| Condition | Multiple Sclerosis |
| Study Type | OBSERVATIONAL |
| Enrollment | 500 participants |
| Start Date | 2024-01-13 |
| Primary Completion | 2025-12 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.
This trial targets 500 participants in total. It began in 2024-01-13 with a primary completion date of 2025-12.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
The goal of this observational study is to evaluate the presence of adverse childhood experiences (ACE) in patients with Multiple Sclerosis. The main questions it aims to answer are: * Does the presence of ACE impact on quality of life of patients with multiple sclerosis? * Does it influence how the patients cope with the disease and with disease course-modifying therapies? During follow up visits, planned as part of their regular medical care, participants will answer survey questions on a tablet .
Eligibility Criteria
Inclusion Criteria: * Age older than 18 years; * Diagnosis of relapsing-remitting multiple sclerosis according to McDonald criteria (2017 revisions) made between 2014 and 2024. * Signature of informed consent Exclusion Criteria: * Presence of language barrier * Presence of conditions that prevent or limit understanding and proper completion of questionnaires
Contact & Investigator
Massimiliano Mirabella, Neurology Associate Professor
✉ massimiliano.mirabella@policlinicogemelli.it📞 0630155390
Frequently Asked Questions
Who can join the NCT06718920 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, studying Multiple Sclerosis. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT06718920 currently recruiting?
Yes, NCT06718920 is actively recruiting participants. Contact the research team at massimiliano.mirabella@policlinicogemelli.it for enrollment information.
Where is the NCT06718920 trial being conducted?
This trial is being conducted at Rome, Italy.
Who is sponsoring the NCT06718920 clinical trial?
NCT06718920 is sponsored by Fondazione Policlinico Universitario Agostino Gemelli IRCCS. The trial plans to enroll 500 participants.
Related Trials
Related Intelligence Guides
In-depth guides covering this condition's trials, eligibility, and what to expect.